05/01/2026
Elecsys PTAU 181 is Roche’s first blood based biomarker designed to help stratify patients undergoing evaluation for Alzheimer’s disease, backed by FDA approval and high precision technology.
An innovative tool that supports more informed and timely clinical decisions.
For sales and support
787-792-2222